australian healthcare

The Aussie biotech space is small but mighty – what will it take to see it surge?

Wilsons Advisory’s Melissa Benson and Shane Storey share their insights in the final part of the biotech mini-series.

It's been a wild ride for ResMed over the past couple of years and while there might be further volatility, things are back on track

The first fund was a hit with investors. Now, Elanor Investors Group are launching a second healthcare real estate fund.

Many businesses are focusing on specialisation, to set themselves apart from their competitors - Real Asset Management is no different

We know that big data is impacting just about everything, so it should come as no surprise that it influences where hospitals are built

Australian investors are savvy when it comes to opportunities in healthcare - but this one has flown under the radar (until now).

How Integral Diagnostics is harnessing AI and teleradiology to scale operations and capitalise on a fragmented imaging market.

The KP Rx Healthcare Opportunities Fund is targeting Australia & New Zealand's most innovative healthcare companies. Find out how they do it

Early-stage healthcare investment is not for the faint-hearted (or under-researched). No one could accuse Hashan De Silva of either.